Related Experiment Video
Updated: Jul 15, 2026
12:09
Protocol for Recombinant RBD-based SARS Vaccines: Protein Preparation, Animal Vaccination and Neutralization Detection
Published on: May 2, 2011
Recombinant vaccine technology in veterinary medicine
1Van Kampen Group, Inc., Hoover, Alabama, USA.
Summary
Recombinant vaccines offer a safe and effective new approach in veterinary medicine. These advanced vaccines provide enhanced stability and can protect animals against multiple diseases with a single dose.
Area of Science:
- Veterinary Medicine
- Vaccinology
- Biotechnology
Background:
- Recombinant technology represents a novel advancement in veterinary vaccine development.
- Traditional vaccines sometimes pose risks or require adjuvants, which recombinant vaccines can avoid.
Purpose of the Study:
- To highlight the advantages and applications of recombinant vaccines in veterinary medicine.
- To showcase the potential for combination vaccines using recombinant platforms.
Main Methods:
- Review of the principles and benefits of recombinant vaccine technology.
- Compilation of currently licensed recombinant veterinary vaccines and their targets.
Main Results:
- Recombinant vaccines offer improved safety, purity, potency, and efficacy.
- Key benefits include pathogen avoidance, no need for adjuvants, and ambient temperature stability.
- This technology enables the creation of multi-valent combination vaccines for animals.
Conclusions:
- Recombinant vaccines are a significant innovation in animal health, offering superior characteristics.
- The flexibility of recombinant technology facilitates the development of diverse and effective vaccines against various animal diseases.
Related Concept Videos
01:09Recombinant DNA
Overview
00:57Viral Recombination
Cells are sometimes infected by more than one virus at once. When two viruses disassemble to expose their genomes for replication in the same cell, similar regions of their genomes can pair together and exchange sequences in a process called recombination. Alternatively, viruses with segmented genomes can swap segments in a process called reassortment.
01:09Recombinant DNA
Overview
01:20The Central Dogma
The central dogma explains the flow of genetic information from DNA nucleotides to the amino acid sequence of proteins.
RNA is the Missing Link Between DNA and Proteins
In the early 1900s, scientists discovered that DNA stores all the information needed for cellular functions and that proteins perform most of these functions. However, the mechanisms of converting genetic information into functional proteins remained unknown for many years. Initially, it was believed that a single gene is...
RNA is the Missing Link Between DNA and Proteins
In the early 1900s, scientists discovered that DNA stores all the information needed for cellular functions and that proteins perform most of these functions. However, the mechanisms of converting genetic information into functional proteins remained unknown for many years. Initially, it was believed that a single gene is...
01:31Hybridoma Technology
Hybridoma technology is used for the large-scale production of monoclonal antibodies. Monoclonal antibodies bind to only a single antigenic determinant or epitope. Such antibodies are used in research, diagnostics, and disease therapy. The hybridoma technology established in 1975 by Georges Köhler and Cesar Milstein was awarded the Nobel Prize in Medicine in 1984 for revolutionizing research and therapy.
Hybridoma Selection
Commonly used fusion techniques — electroporation, polyethylene glycol...
Hybridoma Selection
Commonly used fusion techniques — electroporation, polyethylene glycol...
01:29Microorganisms in Medicine and Therapeutics
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.